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The past is never dead. It’s not even past
William Faulkner (1951)
Bacteria can acquire heritable immunity to viral (phage) enemies by incorporating phage DNA into their
own genome. This mechanism of anti-viral defence, known by the acronym CRISPR, simultaneously
stores detailed information about current and past enemies and the evolved resistance to them. As a
high-resolution genetic marker that is intimately tied with the host–pathogen interaction, the CRISPR
system offers a unique, and relatively untapped, opportunity to study epidemiological and coevolutionary
dynamics in microbial communities that were previously neglected because they could not be cultured in
the laboratory. We briefly review the molecular mechanisms of CRISPR-mediated host–pathogen
resistance, before assessing their potential importance for coevolution in nature, and their utility as a
means of studying coevolutionary dynamics through metagenomics and laboratory experimentation.
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Evolution is explicitly about change over generations, and
that can make it difficult to study when generation times
are long, or when organisms are difficult to routinely
assay. It is therefore convenient when evolution leaves
behind traces of its activity. Fossils record the past, but
offer a poor record of evolution at the molecular level.
Fortunately, evidence of the past is often imprinted
upon DNA sequences. For example, sequence compari-
sons can be used to estimate the proportion of
differences between species that are driven by natural
selection (as opposed to random walks of neutral vari-
ation), and even to estimate the speed at which
adaptation has proceeded (Nielsen 2005). Such analyses
have indicated that, perhaps more than any other class
of genes, those of immune systems tend to evolve adap-
tively and rapidly (Bustamante et al. 2005). This
suggests that host–parasite coevolution plays a central role
in the maintenance of biological diversity (Buckling &
Rainey 2002a; Laine & Tellier 2008). Still, most studies
focus on the past evolutionary record of host defence
genes, or, separately, of parasite infectivity genes, and
thus address coevolution indirectly. Recently, a remark-
able mechanism has been described that may provide,
in the DNA sequence of a single organism, a detailed
molecular record of coevolution. Clustered regularly
interspaced short palindromic repeats (CRISPRs) are
arrays of prokaryotic DNA sequences that mediate a
form of acquired immunity to specific viral pathogens
(Sorek et al. 2008; van der Oost et al. 2009)—somethingr and present address for correspondence: Center d’E´cologie
elle et E´volutive (CEFE)—UMR 5175, 1919 Route de
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in the process provide a record of coevolution past. The
study of this defence mechanism has already revealed
some fascinating molecular biology, but relatively untapped
is the potential to explore the ongoing warfare between
hosts and their phage pathogens in natural environments.2. ACQUIRED, SPECIFIC AND HERITABLE
BACTERIAL RESISTANCE TO VIRAL PATHOGENS
Viruses that infect bacteria (bacteriophages) are ubiqui-
tous in natural bacterial communities (Abedon 2008),
and in some environments outnumber their bacterial
hosts nearly tenfold (Suttle 2005). Bacteria have evolved
a number of phage-resistance mechanisms, such as
adsorption blocking, restricting the injection of phage
genetic material and some abortive infection mechanisms
(Sturino & Klaenhammer 2006). An additional mechan-
ism has recently been added to this list: CRISPRs are
present in bacterial and archaeal genomes, and are
made up of arrays of highly conserved 24- to 47-bp
repeats, separated by variable, often unique spacer
sequences, derived from foreign replicons such as phage
or plasmids (figure 1; Sorek et al. 2008). In a series of ele-
gant experiments (Barrangou et al. 2007; Brouns et al.
2008; Deveau et al. 2008), it was recently shown that:
(i) bacterial cells incorporate phage genetic material into
CRISPRs as spacers; (ii) acquiring these spacers renders
bacterial hosts resistant towards phage that carry the
incorporated sequence; (iii) removal of these spacers
results in the loss of this resistance; and (iv) single
mutations at specific short motifs in the phage genome
are sufficient to evolve counter-resistance (figure 1).
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Figure 1. A schematic representation of CRISPR-mediated phage resistance. CRISPR-associated (Cas) proteins play an impor-
tant role in the initial recognition of phage genetic material and incorporating these proto-spacers in the CRISPR array (1).
Once incorporated, these spacers are then transcribed (2) and used as templates to target homologous phage sequences
within the bacterial cell, again mediated by Cas protein complexes (3). The bottom left of the figure illustrates the specificity
of CRISPR-mediated resistance. While resistance to a specific phage genotype can be acquired by incorporating a spacer
derived from that genotype, point mutations in the phage (represented by the black squares) are sufficient to evade resistance.
Hosts are only able to resist this mutant by incorporating a phage-derived spacer containing the new mutation. This could
lead to an ongoing ‘arms race’, with hosts incorporating more spacers in response to increasing phage mutation accumulation.
The order in which these spacers are incorporated also provides a sequential record of past phage infections.
2098 P. F. Vale & T. J. Little Review. Bacteria–phage coevolutionand pathogen infectivity marks CRISPRs as a potential
molecular mechanism for coevolution.
An integral part of this anti-phage defence mechanism
is the action of CRISPR-associated (Cas) proteins. Cas
proteins are usually found adjacent and upstream of
CRISPR arrays, and show high sequence and structural
similarity to proteins with endonuclease, and DNA- and
RNA-binding functions (Jansen et al. 2002; Wiedenheft
et al. 2009). Because of this feature, they have been
thought to function similarly to RNA-interference
(RNAi) genes (reviewed in Marraffini & Sontheimer
2010a), which themselves mediate a rapidly evolving anti-
viral defence in eukaryotes (Ding et al. 2004; Obbard et al.
2009). However, despite some similarities, their protein
machineries are distinct (Makarova et al. 2006) and,
unlike RNAi, CRISPR–Cas complexes appear to bind
almost exclusively to DNA, suggesting that RNAi and
Cas proteins share little phylogenetic relation (Mojica
et al. 2009).
The molecular details are still being unravelled, but the
anti-viral action of the CRISPR–Cas complex appears to
proceed in three distinct stages (figure 1; reviewed inProc. R. Soc. B (2010)Marraffini & Sontheimer 2010a). In the initial stage of
viral invasion, complexes of Cas proteins target and
cleave short recognition motifs in the phage genome
(Deveau et al. 2008; Mojica et al. 2009), and incorporate
these ‘proto-spacers’ into the host genome at the 50 end of
the CRISPR locus (Barrangou et al. 2007). These short
(23–30 bp) incorporated ‘spacers’ are then transcribed
(stage 2) as CRISPR RNAs (CrRNAs) that contain the
spacer sequence flanked on either side by partial repeat
sequences (Brouns et al. 2008), resulting in large-scale
amplification of that specific sequence. It is still unclear
whether all spacers (e.g. Lillestol et al. 2009) or only the
most recently incorporated (e.g. Brouns et al. 2008) are
transcribed during this step. The final stage involves inter-
ference with phage-derived sequences, again mediated by
Cas-protein complexes, whereby CrRNAs serve as tem-
plates to target conserved viral motifs in subsequent
infections (Brouns et al. 2008). How do CRISPRs
avoid targeting and degrading their own phage-derived
CRISPR spacer? Viral targets are identified by direct
Watson–Crick pairing, and viral degradation seems to
be triggered by mismatches at specific positions between
Review. Bacteria–phage coevolution P. F. Vale & T. J. Little 2099the viral sequence and the repeat sequences flanking the
phage-derived spacer (Marraffini & Sontheimer 2010b).
Therefore, CRISPRs are truly a microbial immune
system (Horvath & Barrangou 2010), allowing strain-
specific resistance to be acquired, a memory of past infec-
tions that permits resistance against future encounters,
while assuring host integrity through self/non-self
discrimination.
How common is CRISPR-mediated defence in nature?
Recently, identifying and characterizing the diversity of
CRISPR–Cas complexes in the wild has been made poss-
ible by high-throughput next-generation sequencing
technologies (Mardis 2008). Using a metagenomic
approach (Hugenholtz & Tyson 2008), environmental
samples can be entirely sequenced and screened with
recently developed CRISPR- and Cas-finding algorithms
(Haft et al. 2005; Bland et al. 2007; Edgar 2007; Grissa
et al. 2007, 2008a), which are now freely available
through web-based resources (Grissa et al. 2008b; also
see CRISPR databases at http://crispr.u-psud.fr and
http://crispi.genouest.org). These ever-growing interactive
databases find CRISPR–Cas complexes in roughly 40 per
cent of bacterial and nearly 90 per cent of archaeal
genomes tested so far. Up to 45 Cas protein families
have been described based on amino acid sequences
(Haft et al. 2005). Two of these proteins, Cas 1 and
Cas 2, seem to be present among all CRISPR systems
described to date, and so offer potential universal markers
of CRISPR-mediated defence systems in microbes
(Makarova et al. 2006; Sorek et al. 2008). The crystal
structure of Cas 1 indicates that it has a metal-dependent
DNase activity, so it is thought to be involved in the initial
recognition and acquisition of viral motifs (Wiedenheft
et al. 2009), whereas Cas 2 has been shown to cleave
single-stranded RNA within U-rich regions.
Beyond mechanisms, CRISPRs offer a unique window
into the history of bacteria–phage warfare, as exposure to
a specific combination of phage strains leaves behind a
unique set of spacers in the host bacterial genome that
simultaneously represents both infective phage strains
that have been prevalent in the environment and the
specific resistance bacteria have acquired. Because
phage-derived spacers are incorporated at the CRISPR
50 leader sequence (Barrangou et al. 2007), the ordered
sequence of spacers essentially gives a temporal record
of the infection history in that bacterial population.
Hence, CRISPRs offer a high-resolution method for mol-
ecular typing of bacterial hosts and their pathogens based
on the unique CRISPR signature. Such record-keeping of
both host and pathogen genetic variation over time is
unparalleled in any other host–pathogen system. There-
fore, CRISPRs might be especially informative in
determining the history of phage host ranges, which
would be impossible to determine from other resistance
mechanisms. Below we highlight how CRISPRs offer
a valuable tool for studies of coevolution, both in the
laboratory and, importantly, in the wild.3. PATTERNS OF ADAPTATION IN SPACE AND TIME
Bacterial CRISPRs offer a unique opportunity to address
questions of coevolutionary dynamics in natural popu-
lations, because only bacteria, which contain a record of
both their evolution and phage evolution in theirProc. R. Soc. B (2010)CRISPR signatures, need to be sampled. Crucially, meta-
genomic analyses can be carried out without the need to
culture bacteria in the laboratory, which means that
CRISPR-mediated coevolution can be studied in non-
cultivable bacteria. This approach potentially permits
coevolutionary dynamics to be studied in detail, either
by geographic sampling to identify patterns of local adap-
tation, or by temporal sampling where hosts and phage
are directly and simultaneously tracked over time.
One of the tenets of host–parasite coevolution is that
antagonistic selection proceeds through local adaptation
of pathogens to common host genotypes, followed by
counter-adaptation of hosts (Hamilton 1993; Woolhouse
et al. 2002). Accordingly, the most common method for
inferring coevolution in wild populations is to sample
over geographic space and test whether hosts and para-
sites are locally adapted (Greischar & Koskella 2007).
Recently, this approach has been extended to analyses
of CRISPR sequences from environmental samples. For
example, Kunin et al. (2008) examined samples from
two geographically distant (USA and Australia) sludge
bioreactors. Focusing on the dominant, and as yet uncul-
tured, microbial species (Candidatus Accumulibacter
phosphatis or CAP), analysis of CRISPR arrays gave
strikingly different results from a thorough analysis of
the rest of the bacterial genome. Specifically, analysis of
CRISPR arrays revealed that there were no common
spacer sequences between the two populations, while
there was very little divergence at 48 other loci. To recon-
cile these differences, the authors hypothesized that CAP
strains disperse widely to become genetically homo-
geneous (hence to very low divergence found in most of
the genome), but differences in exposure to local phage
populations lead to rapid divergence of CRISPR loci.
By sequencing the phage meta-genome from the USA
bioreactor, they found 11 CRISPR spacers with matches
to sympatric phage genome fragments. Thus, the
CRISPR record of interaction with phage, coupled with
geographical sampling, suggests a coevolutionary mosaic
that overpowers the effects of dispersal. A similar result
was found in a comparative genomic analysis of Sulfolobus
islandicus CRISPR arrays and spindle-shaped virus (SSV)
sequences, where viruses exhibited clear biogeographic
structure apparently driven by ongoing adaptation to
local host strains (Held & Whitaker 2009).
The importance for coevolution of ecological factors,
such as productivity (Lopez-Pascua & Buckling 2008),
migration (Morgan et al. 2005) and spatial structuring
(Morgan et al. 2007), has been addressed with exper-
imental evolution in controlled laboratory environments.
CRISPR studies such as those described above, which
employ structured sampling strategies, potentially allow
analogous coevolutionary dynamics to be studied in
natural populations. However, a key limitation of
this approach is that inferring local adaptation from the
presence of spacers and the corresponding phage
sequence could be misleading if not all spacers are
always expressed (e.g. Brouns et al. 2008), or if the
CRISPR system is not functional. Metagenomic studies
in conjunction with phenotypic assays of phage infectivity
on local bacterial hosts would unequivocally determine
the level of local adaptation, but in many cases laboratory
cultures of microbes are difficult to establish (but see Vos
et al. 2009).
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ture the vast majority of bacteria does not necessarily
stop us from accurately inferring coevolutionary
dynamics. This is certainly the case for microbial biofilms
of thermophilic (Synechcoccus thermophilus) or acidophilic
(Leptospirillum) bacteria and their natural phage patho-
gens (Tyson & Banfield 2008; Heidelberg et al. 2009).
Comparative genomics of CRISPR arrays with the viral
meta-genomes from these environments demonstrated a
history of selective sweeps at a CRISPR locus (Tyson &
Banfield 2008) and an abundance of single-nucleotide
polymorphisms in the viral sequence corresponding to
all but the most recently incorporated spacers (Heidelberg
et al. 2009). This suggests a scenario of rapid coevolution-
ary interactions between the microbial hosts and phage
that maintains population-wide genetic diversity. It
appears that such records of coevolution past may run
extremely deep. For example, CRISPR from Leptospirillum
populations found in acid mine drainage and subaerial
biofilms (398C, pH approx. 1; Andersson & Banfield
2008) were found to contain 37 distinct CRISPR arrays
containing a total of 6044 spacer sequences (of which
2348 were unique). Most of these were of viral origin
(up to 40 per cent at a single CRISPR locus), although
some came from extrachromosomal elements such as plas-
mids and transposons, indicating that CRISPR loci may,
for reasons that are not yet clear, contain records of other
types of partnership (Marraffini & Sontheimer 2008).
The studies described above used a spatial sampling
strategy to test for local adaptation. Such spatial patterns
of local adaptation can indirectly indicate the action of
coevolution, but regular and frequent sampling through
time offers a more direct window on the process. As
with spatial sampling, it would add value to confirm
field patterns of phage adaptation with laboratory exper-
imentation, specifically via time-shift experiments,
where antagonists are sampled at different time points
and controlled infections carried out between them
(Gaba & Ebert 2009). By observing the patterns of infec-
tivity among these combinations, one may infer the
underlying coevolutionary dynamics (Gandon et al.
2008). Time-shift experiments have been achieved, for
example, in laboratory studies of Pseudomonas bacteria
and phage (Buckling & Rainey 2002b; Brockhurst et al.
2003), and on larger organisms in the field by collecting
resting eggs of Daphnia and long-living parasite trans-
mission spores from dated lake sediment cores
(Decaestecker et al. 2007). What has never been achieved
is a union of field observation, phenotypic assays and
documentation of their molecular underpinnings. One
test of parasite local adaptation in a plant–pathogen
system (Laine 2007) reported discordant results when
measuring parasite fitness in either a field-transplant exper-
iment or a laboratory cross-infection experiment. If
CRISPRs are employed to investigate patterns of coevolu-
tion across time or space in a bacterial system that is also
amenable to laboratory culture, the intersection between
laboratory and field-based investigations would provide
clear benefits to our understanding of local adaptation
and coevolutionary dynamics (Nuismer & Gandon 2008).
Work in some host–pathogen systems has sought to
infer the nature of coevolutionary dynamics from the
underlying genetics of infection. Most notably, workers
have compared the propensity of the ‘gene-for-gene’ andProc. R. Soc. B (2010)‘matching allele’ infection models to promote and main-
tain genetic polymorphism (Agrawal & Lively 2002).
However, in conventional models, resistant phenotypes
are derived by mutations on the host genome, whereas
CRISPR-mediated resistance is explicitly linked to gen-
etic variance in the prevailing pathogen population. It is
therefore difficult to predict CRISPR-mediated coevolu-
tionary dynamics without some knowledge of the
infection genetics particular to this mechanism. For
example, CRISPR-mediated systems suggest exquisite
specificity: hosts are no longer protected from phage that
acquires a single mutation in spacer-derived sequences.
These phages are thus universally infective and should
quickly sweep to high frequency. Will this happen so fast
that the new phage mutants quickly fix in populations,
eroding genetic variation in the process? Or will acquisition
of a phage-derived spacer into a CRISPR locus occur
quickly enough to halt the march to fixation? It is presently
unclear how rapidly populations can acquire resistance via
CRISPR; that is, what proportion of infected host cells
incorporate viral spacers before lysis occurs.
One may also speculate on the relative importance
of CRISPR-based resistance relative to other phage-
resistance mechanisms, such as cell-surface receptor
modification. Receptor modification offers a first line of
defence that impedes the entry of most phages, but
mutations at these receptors often come at some meta-
bolic cost to the host, as they are the same receptors
involved in nutrient uptake (e.g. Ferenci et al. 1980). In
addition, viral population sizes and mutation rates are
much higher than for their bacterial hosts (Drake et al.
1998), so such resistance can in principle be easily
evaded. Depending on how efficient spacer acquisition
by CRISPRs is, such a second line of defence once
phage have entered the host cell could relax the costs
associated with receptor modification, and also provide
an invaluable chance of halting infection once counter-
resistance to receptor modification has occurred. This
interplay between CRISPR and other defence mechan-
isms is yet to be explored, and addressing these issues
will tell us much about the genetic constraints on
CRISPR-mediated resistance evolution (in particular,
the rates at which CRISPRs evolve relative to changes
in pathogen-imposed selection over time).4. MEASURING THE COSTS OF CRISPR-MEDIATED
RESISTANCE
Coevolutionary dynamics and levels of polymorphism in
resistance are tightly linked with the costs associated
with resisting infection (Antonovics & Thrall 1994).
Costs of resistance are a common feature of most host–
parasite systems (Sheldon & Verhulst 1996), and reveal
a trade-off (a negative co-variance) between resistance
and other life-history traits (e.g. Kraaijeveld & Godfray
1997). If CRISPR-mediated resistance were not costly,
we would expect an indefinite accumulation of phage-
derived spacers in the host genome. There may be costs
associated with CRISPR length, or with the number of
CRISPRs on the genome, and such costs may maintain
polymorphism in the number and identity of spacers
present in the bacterial population. So far, measurements
of costs of resistance in wild bacteria–phage systems are
limited (Lennon et al. 2007), and whether CRISPR is
Review. Bacteria–phage coevolution P. F. Vale & T. J. Little 2101costly owing to acquisition of additional spacers has yet to
be tested.
There are several potential ways that CRISPRs might
be a costly system. As hosts incorporate more spacers
(figure 1), longer CRISPR arrays may simply take
longer to replicate, resulting in reduced growth rate. A
linked issue is that as CRISPR arrays get longer, the tran-
scription of the repeat sequence separating phage-derived
spacers may cause loss of replication fidelity during cell
division, similar to what occurs in microsatellites
(Bzymek & Lovett 2001). Hence, hosts with long
CRISPR arrays might accumulate a larger number of
deleterious mutations and, consequently, have lower
fitness. Considering how CRISPRs might be costly high-
lights several unknowns about how this mechanism
provides a memory of past infections. How many spacers
are expressed during infection? That is, do CRISPR loci
allow memory against enemies from the distant past, or
are defences maintained only for the most recent patho-
genic encounters? Are there physiological costs of
expressing many spacers? Does variation in CRISPR
array size correlate with the diversity of phage that hosts
are exposed to? A recent theoretical exploration of the
evolution of gene expression in host–parasite systems
(Nuismer & Otto 2005) found that, while coevolution
often favours the co-expression of resistance alleles in
hosts (maximizing the chances of pathogen recognition),
this depends on the underlying infection genetics and
on the costs of resistance. While measuring costs of resist-
ance is often challenging (Pease & Bull 1988; Mealor &
Boots 2006), if CRISPRs can be incorporated into
a laboratory system then we could exploit the practical
advantages of experimental evolution with microbes
(Jessup et al. 2004; Buckling et al. 2009) to quantify the
mode and strength of selection on CRISPR-mediated
resistance in controlled environments.5. EXPERIMENTAL EVOLUTIONARY EPIDEMIOLOGY
Evolutionary biology is, in principle, well poised to under-
stand the processes and mechanisms that underpin
changing pathogenicity, with well-established general the-
ories of adaptation (Fisher 1930; Price 1972), invasion
dynamics (May et al. 2001; Schreiber & Lloyd-Smith
2009) and host–pathogen coevolution (Anderson &
May 1982; Best et al. 2009; Gandon & Day 2009). But
how do evolution and epidemics interact to determine
the population burden of disease? A key challenge for
future research is to establish an experimental system
where CRISPRs may directly inform on viral epidemiolo-
gical and evolutionary dynamics in natural populations.
What is required is a host–pathogen system where it is
possible to monitor epidemics regularly and to identify
host and pathogen genotypes present during all stages
of epidemic onset. Microbial systems where seasonal
viral epidemics are known to occur (e.g. Yoshida et al.
2008) would appear to be good candidates for such
studies, and if CRISPRs are added to the equation,
there is the potential for frequent field sampling to
reveal the genetic details of epidemic onset. The
advantage of CRISPRs would be in providing a high-
resolution genetic marker that recapitulates the history
of infections in the host genome and allows individual
phage strains to be tracked by following their presenceProc. R. Soc. B (2010)on these same host genomes. With this information in
hand, it is then possible to begin addressing specific ques-
tions about the dynamics of adaptation in the context of
epidemic spread: does pathogen adaptation occur mainly
from standing genetic variation or from novel mutation
(Hermisson & Pennings 2005; Barrett & Schluter 2008)?
What effect do bottlenecks have on the contributions of
selection or drift during pathogen emergence (Dlugosch
& Parker 2008)? Is there clonal interference between invad-
ing strains during epidemic onset (Miralles et al. 1999;
Pepin & Wichman 2008), and how does recombination
between them affect the epidemiological dynamics (Cole-
grave 2002; Cooper 2007)?
While the existence of CRISPR arrays in prokaryotes
was originally recognized in the late 1980s (Ishino et al.
1987), appreciation of their role in mediating resistance
against viral pathogens is very recent. The meta-
genomic-based CRISPR studies described here have
already demonstrated the potential to observe bacteria
and phage coevolution in their natural settings and in
real time, but many opportunities for fieldwork remain.
Characterizing this mechanism in host–pathogen systems
that are known to coevolve and are amenable to labora-
tory life (e.g. Vos et al. 2009) will further expand the
range of questions that can be explored, but the key
opportunity would seem to be the possibility of detailed
analysis of coevolution in the wild. The molecular book-
keeping of the CRISPR system may thus help unravel
the nature of the coevolutionary process under natural
conditions of temporal and spatial environmental
heterogeneity.T.J.L. and P.F.V. are funded by a Wellcome Trust Senior
Research Fellowship in Basic Biomedical Sciences awarded
to T.J.L.
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